Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiotensin II Antagonism of TGF-Beta 1: A Candesartan Dose - TGF-Beta 1 Response Relationship Study

NCT00320970 is registered in ClinicalTrials.gov with Providence Health & Services as lead sponsor.

NCT NCT00320970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00320970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiotensin II Antagonism of TGF-Beta 1: A Candesartan Dose - TGF-Beta 1 Response Relationship Study
Lead sponsor
Providence Health & Services
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2002
Completion date
September 30, 2004
Enrollment
36
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy, hypertension